oral semaglutide nejm New in the May 29, 2025, issue of NEJM: Sotatercept in Pulmonary Arterial Hypertension (ZENITH phase 3 trial) https://nej.md/4iYkLbj and Cardiovascular Outcomes (SOUL trial) https://nej.md/4hHII5M Upadacitinib for Giant-Cell Arteritis obesity #diabetes #endocrinology #glp1 #obesitytreatment

Learn why dose-splitting compromises treatment, the risks involved, and evidence-based strategies to manage side effects safely under UK clinical guidance.

Additionally, it covers how to use Skinny RX, potential side effects,

AIDS WEIGHT-LOSS

The spot where you inject your GLP-1 or GIP medication, like Ozempic, Wegovy, Zepbound or Mounjaro, could be the secret weapon or the silent saboteur in your...

As these medications surge in popularity for both diabetes and weight loss management, clinicians are beginning to observe a pattern: patients reporting skin sensitivity, burning sensations, and confirmed cases of shingles